INSR and type 2 diabetes mellitus: Recently, using myoblasts generated from iPSCs (iMyos) of individuals over the range of insulin sensitivity, including patients with insulin receptor mutations (43), patients with T2D (15), and individuals without diabetes with insulin resistance (16), we found large differences in the phosphoproteome based on insulin resistance status of the donor.